| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ATMIN ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF722 ZNF735 ZNF260 ZNF483 | 7.84e-08 | 1412 | 18 | 10 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF722 ZNF735 ZNF260 ZNF483 | 4.00e-07 | 1244 | 18 | 9 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF722 ZNF735 ZNF260 ZNF483 | 4.80e-07 | 1271 | 18 | 9 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF722 ZNF735 ZNF260 ZNF483 | 1.54e-06 | 1459 | 18 | 9 | GO:0000977 |
| HumanPheno | Abnormal larynx morphology | 1.55e-03 | 201 | 2 | 2 | HP:0025423 | |
| Domain | KRAB | 3.53e-10 | 358 | 17 | 8 | PS50805 | |
| Domain | KRAB | 3.53e-10 | 358 | 17 | 8 | PF01352 | |
| Domain | KRAB | 4.48e-10 | 369 | 17 | 8 | SM00349 | |
| Domain | KRAB | 4.58e-10 | 370 | 17 | 8 | IPR001909 | |
| Domain | zf-C2H2_6 | 5.98e-09 | 314 | 17 | 7 | PF13912 | |
| Domain | ZINC_FINGER_C2H2_2 | ATMIN ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF735 ZNF260 ZNF483 | 6.28e-09 | 775 | 17 | 9 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ATMIN ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF735 ZNF260 ZNF483 | 6.42e-09 | 777 | 17 | 9 | PS00028 |
| Domain | Znf_C2H2-like | ATMIN ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF735 ZNF260 ZNF483 | 7.93e-09 | 796 | 17 | 9 | IPR015880 |
| Domain | Znf_C2H2 | ATMIN ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF735 ZNF260 ZNF483 | 8.74e-09 | 805 | 17 | 9 | IPR007087 |
| Domain | ZnF_C2H2 | ATMIN ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF735 ZNF260 ZNF483 | 9.03e-09 | 808 | 17 | 9 | SM00355 |
| Domain | - | 5.32e-08 | 679 | 17 | 8 | 3.30.160.60 | |
| Domain | zf-C2H2 | 6.23e-08 | 693 | 17 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 6.30e-08 | 694 | 17 | 8 | IPR013087 | |
| Domain | LIM | 1.76e-03 | 69 | 17 | 2 | PF00412 | |
| Domain | - | 1.82e-03 | 70 | 17 | 2 | 2.10.110.10 | |
| Domain | LIM_DOMAIN_2 | 1.87e-03 | 71 | 17 | 2 | PS50023 | |
| Domain | Znf_LIM | 1.87e-03 | 71 | 17 | 2 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.87e-03 | 71 | 17 | 2 | PS00478 | |
| Domain | LIM | 1.87e-03 | 71 | 17 | 2 | SM00132 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 8.84e-05 | 1387 | 13 | 7 | M734 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.18e-03 | 56 | 13 | 2 | MM17236 | |
| Pubmed | ZFP260 is an inducer of cardiac hypertrophy and a nuclear mediator of endothelin-1 signaling. | 2.53e-07 | 2 | 18 | 2 | 21051538 | |
| Pubmed | MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5. | 1.52e-06 | 4 | 18 | 2 | 25403488 | |
| Pubmed | The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. | 2.29e-05 | 14 | 18 | 2 | 15610731 | |
| Pubmed | Interactome of the negative regulator of nuclear import BRCA1-binding protein 2. | 8.16e-05 | 26 | 18 | 2 | 25820252 | |
| Pubmed | 1.02e-04 | 29 | 18 | 2 | 14563677 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 2.93e-04 | 49 | 18 | 2 | 9630514 | |
| Pubmed | 3.70e-04 | 55 | 18 | 2 | 29997285 | ||
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 3.97e-04 | 283 | 18 | 3 | 18854154 | |
| Cytoband | 7p11.2 | 2.45e-04 | 59 | 18 | 2 | 7p11.2 | |
| Cytoband | 19q13.41 | 4.28e-04 | 78 | 18 | 2 | 19q13.41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p11 | 5.33e-04 | 87 | 18 | 2 | chr7p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 1.04e-03 | 122 | 18 | 2 | chr19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 4.99e-03 | 271 | 18 | 2 | chr7q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.06e-02 | 1192 | 18 | 3 | chr19q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ATMIN ZNF429 ZNF479 ZNF616 ZNF880 ZNF716 ZNF735 ZNF260 ZNF483 | 9.44e-10 | 718 | 15 | 9 | 28 |
| GeneFamily | LIM domain containing | 1.07e-03 | 59 | 15 | 2 | 1218 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.29e-05 | 172 | 18 | 3 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-05 | 176 | 18 | 3 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-05 | 180 | 18 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.27e-05 | 27 | 18 | 2 | 6161ec6700967b00fd24c020751eee913d8127d7 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.14e-03 | 125 | 18 | 2 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| ToppCell | severe_influenza-B_cell|severe_influenza / disease group, cell group and cell class (v2) | 1.19e-03 | 128 | 18 | 2 | 92b250186d6bb08ce4f2f5cc4fb93928f6b92d3a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.31e-03 | 134 | 18 | 2 | b5466759285b4973850afb2e1be7c1d25f1c7927 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-03 | 139 | 18 | 2 | 4efab4421e3448880a1dcf981f6a65131b038010 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-03 | 139 | 18 | 2 | 39f3c28f89c37bb8cc049c56d2948ea906fb3d86 | |
| ToppCell | PBMC-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 1.53e-03 | 145 | 18 | 2 | 23a9a4fd1934c4a38d9259105c1fdbac459575cb | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 1.53e-03 | 145 | 18 | 2 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-03 | 146 | 18 | 2 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-03 | 147 | 18 | 2 | 64fa0753a3a79f492ef8acc6942bf90d379a983f | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.59e-03 | 148 | 18 | 2 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | normal_Lung-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.63e-03 | 150 | 18 | 2 | b81f8dfc7755252c457e38bb32b103af3b6f1c01 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 1.65e-03 | 151 | 18 | 2 | 9bfb807e1180b31fa9a2c500ce993de9707c070f | |
| ToppCell | PBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters | 1.70e-03 | 153 | 18 | 2 | 4ee37266b0054f276c7a73ab9220f681b9d74c71 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 1.78e-03 | 157 | 18 | 2 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-03 | 159 | 18 | 2 | 709b57f992a29878cc899d760d144d36cb5cb280 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-03 | 160 | 18 | 2 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | Control-Mast_cells-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 1.88e-03 | 161 | 18 | 2 | 5807ee48f871a3eb24ebf78fd107cf5f2a4ec846 | |
| ToppCell | COVID-19_Severe-PLT_3|COVID-19_Severe / Disease Group and Platelet Clusters | 1.88e-03 | 161 | 18 | 2 | cd4ed3fa3cd8b159ab10cf9b2ad5cd05640530d0 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.92e-03 | 163 | 18 | 2 | e393e5ff885a42b2b44e430d3d5a58f5e50eb732 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.94e-03 | 164 | 18 | 2 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.94e-03 | 164 | 18 | 2 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-03 | 166 | 18 | 2 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-03 | 166 | 18 | 2 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.99e-03 | 166 | 18 | 2 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 2.02e-03 | 167 | 18 | 2 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.02e-03 | 167 | 18 | 2 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.04e-03 | 168 | 18 | 2 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.04e-03 | 168 | 18 | 2 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-03 | 169 | 18 | 2 | 0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-03 | 170 | 18 | 2 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.09e-03 | 170 | 18 | 2 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.14e-03 | 172 | 18 | 2 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-03 | 172 | 18 | 2 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | Influenza_Severe-CD4+_Tcm|Influenza_Severe / Disease group and Cell class | 2.14e-03 | 172 | 18 | 2 | 47865a04968ca28c6ff125159d9a23e37c8b8af1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-03 | 173 | 18 | 2 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-03 | 173 | 18 | 2 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-03 | 174 | 18 | 2 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-03 | 175 | 18 | 2 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-03 | 176 | 18 | 2 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-03 | 177 | 18 | 2 | c20df760b25caa772278397b02fc36521927cbfc | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-03 | 178 | 18 | 2 | 5fc9f41609735b972a2cd0830182d13742cd5bf5 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.28e-03 | 178 | 18 | 2 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-03 | 179 | 18 | 2 | c09c3eed43d1aa3b7aa8f3021e6f2737840cde16 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-03 | 179 | 18 | 2 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | Endothelial|World / shred by cell class for turbinate | 2.31e-03 | 179 | 18 | 2 | 052b2681974be00efb8503fa4e2c85d91d5ebd06 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-03 | 179 | 18 | 2 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-03 | 179 | 18 | 2 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-03 | 179 | 18 | 2 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-03 | 180 | 18 | 2 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-03 | 180 | 18 | 2 | 410ea13a9c00cf54b4d47c72404dfe893c086d87 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-03 | 180 | 18 | 2 | 63e7ec20a93452a02bf904acebdbe3d0d9ae8894 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-03 | 181 | 18 | 2 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-03 | 181 | 18 | 2 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-03 | 181 | 18 | 2 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.36e-03 | 181 | 18 | 2 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-03 | 181 | 18 | 2 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.36e-03 | 181 | 18 | 2 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-03 | 181 | 18 | 2 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-03 | 181 | 18 | 2 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-03 | 181 | 18 | 2 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-03 | 182 | 18 | 2 | f00eec1f434d92d44787d3d3343476c98c3de5b4 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.39e-03 | 182 | 18 | 2 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.39e-03 | 182 | 18 | 2 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-03 | 182 | 18 | 2 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.39e-03 | 182 | 18 | 2 | db5d6c5e7d59734653906b126f2c1d57461a5290 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-03 | 182 | 18 | 2 | 7b86703559438e2d5ef3dad963ee0d772513f313 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 2.39e-03 | 182 | 18 | 2 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.41e-03 | 183 | 18 | 2 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-03 | 183 | 18 | 2 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.41e-03 | 183 | 18 | 2 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 2.41e-03 | 183 | 18 | 2 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-03 | 183 | 18 | 2 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-03 | 184 | 18 | 2 | 840fac463665ed18752f402f7d1ef2e5052bdf74 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.44e-03 | 184 | 18 | 2 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-03 | 184 | 18 | 2 | 5cfc19ffb9f074bdf0d81c86e212a708ec141631 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-03 | 184 | 18 | 2 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | P28-Endothelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.44e-03 | 184 | 18 | 2 | b056411f499866097f4322999cfd1e57a3927b78 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-03 | 184 | 18 | 2 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-03 | 184 | 18 | 2 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-03 | 185 | 18 | 2 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-03 | 185 | 18 | 2 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-03 | 185 | 18 | 2 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-03 | 185 | 18 | 2 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | metastatic_Brain-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 2.46e-03 | 185 | 18 | 2 | 2eee26c28b130be6163f27bc608384c054238501 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-03 | 185 | 18 | 2 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-03 | 185 | 18 | 2 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-03 | 185 | 18 | 2 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-03 | 185 | 18 | 2 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.49e-03 | 186 | 18 | 2 | 26a625ca0300055d6af3472aa0bfba59b73db292 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-03 | 186 | 18 | 2 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-03 | 186 | 18 | 2 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.49e-03 | 186 | 18 | 2 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 187 | 18 | 2 | ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 187 | 18 | 2 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.52e-03 | 187 | 18 | 2 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-03 | 188 | 18 | 2 | 9155b9a92496e75646778c025b02947e9e9ec73a | |
| Disease | pancreatic carcinoma | 4.44e-03 | 174 | 17 | 2 | EFO_0002618 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKVLCSTGGKKHYNF | 916 | Q8N7Z5 | |
| KRGSHKDYKKGKACT | 71 | Q7RTP6 | |
| GKKYVQKDGHHCCLK | 16 | Q13642 | |
| AEKKHKCSKCSNSYG | 161 | O43313 | |
| NHKKGKDCSKLGKKC | 141 | P05305 | |
| LHGQNKKYKNCSTGK | 2031 | Q7Z5N4 | |
| KHYKCEKCGKDFKQS | 286 | Q8NE65 | |
| HTGEKLYKCNKCGKV | 346 | Q6PDB4 | |
| GKKHLKCKKYGKSFC | 181 | P0CB33 | |
| HTGQKTYKCNKCGKV | 431 | Q08AN1 | |
| SHTGKKAYKCNKCGK | 76 | Q3ZCT1 | |
| GKKHFKCKNDGKSFC | 181 | A6NP11 | |
| VLKCGHKYHKGCFKQ | 1971 | P53804 | |
| GKCIGKSKCKCSKGY | 286 | Q9Y5W5 | |
| GKCGHEKLQFKKCCK | 116 | Q96JC4 | |
| RHTGKKPFQCKKCGK | 166 | Q86V71 | |
| EKTHKCSKCGKAFGY | 436 | Q8TF39 | |
| GKKHFKCKKYGKSFC | 181 | A0A1W2PQL4 |